Opiate Use and Biliary Dilation
Trial ID or NCT#
Status
NOT RECRUITING
Purpose
We hope to better define the association between opiate use and biliary dilation, which was evident in our previous retrospective study. This prospective study including all endoscopic ultrasound procedures performed for further evaluation of biliary dilatation in the setting of bilirubin \<2 mg/dL will enable accurate measurement of common bile duct and pancreatic duct diameter using endoscopic ultrasound and identification of other non- obstructive factors which may modulate biliary dilation (i.e. age, cholecystectomy status, duration and type of opiate used).
Official Title
Prospective Evaluation of Opiate Use Status in Patients Referred for Endoscopic Evaluation of Bile Duct Dilation
Eligibility Criteria
- 1. Referral/consultation for consideration for EUS ± ERCP2. Age 18 and older3. Evidence of biliary dilation on abdominal imaging without obstructive pattern on liver function tests or imaging.4. Willing and able to comply with the study procedures and provide written informed consent to participate in the study.
- 1. Age \<182. Potentially vulnerable subjects including, homeless people, pregnant females, employees and students.3. Participation in another investigational study that may directly or indirectly affect the results of this study within 30 days prior to the initial visit4. Other biliary process which accounts for patient's abnormal liver function studies/imaging (i.e. mass, stone, cirrhosis).
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Subhas Banerjee
650-723-2623
View on ClinicalTrials.gov
